Confirmation of cause and manner of death via a comprehensive cardiac autopsy including whole exome next-generation sequencing

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 8, 2014, Pages 1083-1089

  Loporcaro, Christina G ^a   Tester, David J ^b   Maleszewski, Joseph J ^b   Kruisselbrink, Teresa ^b   Ackerman, Michael J ^b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MYOSIN; DNA; MYH7 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CHEMISTRY; DNA SEQUENCE; EXOME; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENETICS; HEART MUSCLE; HIGH THROUGHPUT SEQUENCING; HUMAN; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; SUDDEN DEATH;

ADOLESCENT; AMINO ACID SUBSTITUTION; AUTOPSY; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CAUSE OF DEATH; DEATH, SUDDEN; DNA; EXOME; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; MYOCARDIUM; MYOSIN HEAVY CHAINS; SEQUENCE ANALYSIS, DNA;

EID: 84907267767     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0479-SA     Document Type: Article

References (22)

1. Virmani R, Burke A, Farb A. Sudden cardiac death. Cardiovasc Pathol. 2001;10(6): 275-282.
2. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334(16): 1039-1044.
3. Tester DJ, Ackerman MJ. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu Rev Med. 2009;60(1): 69-84.
4. Tester D, Ackerman M. The molecular autopsy: should their evaluation continue after the funeral? Pediatr Cardiol. 2012;33(3): 461-470.
5. Semsarian C, Hamilton R. Key role of the molecular autopsy in sudden unexpected death. Heart Rhythm. 2012;9(1): 145-150.
6. Skinner JR, Duflou JA, Semsarian C. Reducing sudden death in young people in Australia and New Zealand: the TRAGADY initiative. Med J Aust. 2008; 189(10): 539-540.
7. Basso C, Burke M, Fornes P, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452(1): 11-18.
8. Ackerman M, Priori S, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8): 1308-1339.
9. Tester D, Medeiros-Domingo A, Will M, Haglund C, Ackerman M. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsynegative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc. 2012;87(6): 524-539.
10. Skinner J, Crawford J, Smith W, et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm. 2011;8(3): 412-419.
11. Gladding P, Evans C, Crawford J, et al. Posthumous diagnosis of long QT syndrome from neonatal screening cards. Heart Rhythm. 2010;7(4): 481-486.
12. Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008;18(11): 1851-1858.
13. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14): 1754-1760.
14. Asmann YW, Middha S, Hossain A, et al. TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data. Bioinformatics. 2012;28(2): 277-278.
15. Clarke L, Zheng-Bradley X, Smith R, et al. The 1000 Genomes Project: data management and community access. Nat Methods. 2012;9(5): 459-462.
16. Exome Variant Server NESPE. Seattle, WA. http://evs.gs.washington.edu/ EVS/. Accessed September 18, 2013.
17. Exome Chip Design. http://genome.sph.umich.edu/wiki/Exome-Chip-Design. Accessed September 18, 2013.
18. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326(17): 1108-1114.
19. Roopnarine O, Leinwand LA. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J. 1998;75(6): 3023-3030.
20. Crotti L. Genetic predisposition to sudden cardiac death. Curr Opin Cardiol. 2011;26(1): 46-50.
21. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail. 2009;2(3): 253-261.
22. Ingles J, Yeates L, Semsarian C. The emerging role of the cardiac genetic counselor. Heart Rhythm. 2011;8(12): 1958-1962.